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• MicroRNAs (miRNAs) are small noncoding RNAs which 
enhance the cleavage or translational repression of 
specific mRNA with recognition site(s) in the 3’-
untranslated region (3’UTR).  
 
• The biogenesis of miRNA is controlled by two RNase-
dependent processing steps that converts a long primary 
transcript into a mature ~20 nt miRNA. 
 
•  The mature miRNA are released and then loaded onto 
the miRNA-induced silencing complex (miRISC), which 
acts as a guiding strand to recognize specific mRNA 
targets. 
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Canonical generation of pre-miRNAs 
• miRNA genes are transcribed in the nucleus mainly by 
RNA polymerase (pol) II into stem-loop structured 
primary miRNAs (pri-miRNAs). 
 
•  Harboring a 5’ m7G cap and a 3’ poly(A) tail, these pri-
miRNAs are then trimmed into ~60 to 70-nt miRNA 
precursors (pre-miRNAs) by the nuclear ribonuclease 
(RNase) III Drosha, acting in concert with the DiGeorge 
syndrome critical region 8 (DGCR8) protein within the 
microprocessor complex.  
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Noncanonical generation of pre-miRNAs 
• in which certain debranched small introns mimic 
the structural features of pre-miRNAs to enter 
the miRNA-processing pathway without Drosha-
mediated cleavage, named “mirtrons”, has been 
described initially in Drosophila, but are also 
present in mammals. To date, no viral “mirtrons” 
have been reported. 
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• The canonical and noncanonical pre-miRNAs 
are subsequently exported to the cytoplasm via 
Exportin-5, and the base of their stem is 
recognized by the PAZ domain of Dicer. 
 
•  Acting as an intramolecular dimer, Dicer RNase 
IIIa and IIIb domains cleave the stem at the base 
of the loop to generate a miRNA:miRNA* duplex. 
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• The transactivating response RNA-binding protein 
(TRBP) has been shown to operate with Dicer within a 
pre-miRNA processing complex, although their precise 
mechanistic interaction remains elusive. Following a 
strand selection and separation step, which is based on 
the thermodynamic stability of the RNA duplex, the 
miRNA strand (~21 to 24-nt) with the least stable 5’ end 
pairing (called the guide strand) is incorporated into 
effector miRNA-containing ribonucleoprotein (miRNP) 
complexes containing Argonaute 2 (Ago2), TRBP and 
Dicer, guiding them toward specific messenger RNAs 
(mRNAs). 
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• Cellular miRNAs have been shown to control various 
processes such as cell proliferation, apoptosis and 
hematopoietic cell differentiation. As for viral miRNAs, 
they can regulate expression of viral as well as host 
proteins by directing repression or cleavage of mRNA 
transcripts, thereby inhibiting key cellular processes 
involved in the response to viral infection. 
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miRNAs in cancer 
• Genome-wide miRNA expression profiling analyses have 
reported a general dysregulation of miRNA expression in 
all tumors. To date, over 1000 miRNAs have been 
reported in humans (miRbase:1527 at November 2011), 
and hundreds of them map to chromosomic regions that 
are known to be altered in human cancer, such as loss 
of heterozygosity regions (LOH) (e.g. miR-15a/16-1), 
amplified regions (e.g. miR-17–92 cluster, miR-155), and 
breakpoint regions and fragile sites (FRA) (e.g. let-7 
family members). 
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• Published studies have defined that elevated expression 
of some miRNAs (oncogenes) as well as down-
regulation of others (tumor-suppressors) accompanies 
carcinogenesis and correlates with the development of 
cancer-associated phenotypes. 
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Emerging roles of miRNAs in cancer 
1. Tumorigenesis 
2. Tumor metastasis 
3. Drug resistance 
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Emerging roles of miRNAs in cancer tumorigenesis 
1. Let-7 is the most studied miRNA both in development and cancer. 
The human let-7 family comprises 12 closely related members of 
miRNA (let-7-a-1, a-2, a-3, b, c, d, e, f-1, f-2, g, i and miR-98).  
It was reported that let-7 is downregulated in lung cancer and is 
associated with elevated RAS expression. They further showed 
that let-7 is complementary to multiple sites in the 3’UTR of the 
human RAS genes, allowing let-7 to suppress the expression of K-
RAS and N-RAS. The tumor suppressive roles of let-7 are further 
strengthened by its antagonistic roles toward the expression of 
multiple oncogenes including RAS, MYC, and other cell cycle 
regulators in a variety of human cancer tissues. 
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2. MiRNAs derived from miR-17-92 cluster, which contains seven 
homologous miRNAs, including miR-17-3p, miR-17-5p, miR-18a, 
miR-20a, miR-19a, miR-19b-1, and miR-92a-1, have been 
identified as oncogenic miRNAs. These miRNAs target multiple 
genes involved in proapoptotic pathways, reflecting their 
oncogenic activities.  
3. MiR-21 has been shown to be overexpressed in a wide variety of 
cancers, including malignant human glioblastoma tumor tissues. 
Knockdown of miR-21 induced activation of caspases and resulted 
in apoptosis in glioblastoma cells. 
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The roles of miRNAs in tumor metastasis 
• MiR-10b is the most studied miRNA with metastasis-promoting 
effect and is directly regulated by Twist1, an oncoprotein 
facilitating epithelial-mesenchymal transition (EMT). Expression of 
miR-10b is markedly elevated and maintains the invasiveness of 
metastatic human breast cancer cells. Overexpression of miR-10b 
in non-metastatic breast cancer cells results in enhanced 
invasiveness and distant metastasis. 
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Functions of miRNAs in drug resistance 
• MiR-519c was first found to increase drug sensitivity of colon 
cancer cells by regulating ABCG2 and was later shown to 
suppress the expression of HIF-1α which consequently attenuates 
tumor angiogenesis 
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Mechanisms of dysregulation 
of miRNAs in cancer 
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1. Genomic abnormalities 
• Like protein-coding 
genes, more than half of 
miRNA genes in human 
cancers are located in 
chromosomal regions 
that frequently exhibit 
amplification, deletion, or 
translocation 
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Examples 
• The region 13q14 of the chromosome where miR-15 and miR-16 are 
located and frequently deleted in B cell chronic lymphocytic 
leukemias (B-CLL), resulting in the loss or downregulated 
expression of miR-15 and miR-16.  
• Deletion of miR-17-92 cluster exists in melanomas, ovarian, and 
breast cancers. 
• The oncogenic miR-155 was found to be upregulated along with its 
host gene, BIC, in Burkitt's lymphoma patients.  
 
• These studies provide an important connection between the 
expression of miRNAs and genomic deletion/amplification in cancer. 
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2. CpG methylation and histone modification 
• Transcriptional silencing of tumor suppressor genes by CpG island 
promoter hypermethylation is a common hallmark of cancer.  
• Similar phenomenon has been identified in miRNA regulation in 
which Saito et al. showed that a subset of miRNAs is upregulated by 
treatment of inhibitors specific for DNA methylation (5-aza-20-
deoxycytidine) or histone deacetylase (4-phenylbutyric acid) in 
cancer cells. 
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Examples 
• miR-127 is downregulated in human cancers. MiR-127 is embedded in a 
CpG island and dramatically upregulated through its own promoter, 
suggesting that DNA methylation or histone modification at this promoter 
region hinders the expression of miR-127 in cancer cells. The downstream 
target of miR-127, Bcl-6, is also consistently repressed after the treatments. 
 
• It was investigated the profile of miRNA expression in cells lacking DNA 
methyltransferases and found that miRNA-124a is downregulated by CpG 
island hypermethylation. This epigenetic silencing subsequently activates 
CDK6 and induces Rb phosphorylation. 
 
• One of the let-7 genes, Let-7a-3, is also located within the CpG islands. It 
was found that let-7a-3 gene is hypermethylated in ovarian cancer and 
hypermethylated let-7a-3 is associated with downregulation of IGFII 
expression and poor prognosis in ovarian cancer patients, suggesting that 
let-7 expression may target IGF-II. 
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3. Transcriptional regulation 
• miRNA expression is also regulated by transcription factors.  
• p53 is a fundamental tumor suppressor which transcriptionally 
regulates hundreds of protein coding genes. In 2007, three studies 
that published at the same time uncovered the subsets of miRNA 
regulated by p53. They analyzed the profiles of p53-dependent 
miRNA expression and found that a family of these miRNAs, miR-
34a-c, was consistently upregulated by p53, which directly 
recognizes the promoters and activates the transcription of these 
miRNAs. These miRNAs function as powerful effectors to control 
p53-mediated cell cycle arrest and apoptosis 
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• It was identified another tumor suppressor miRNA, miR-200c, that is 
also controlled by p53. 
•  Through binding to the miR-200c promoter, p53 induces miR-200c 
expression and consequently attenuates EMT and reduces stem-
cell-like population in breast cancer by targeting ZEB1 and BMI1, 
respectively 
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4. Abnormal maturation pathways 
• After generation of primary miRNAs, a two-step Rnase-dependent 
• maturation pathway is required to produce mature miRNAs. 
•  First, primary miRNAs (primiRNA) are processed by Drosha-containing 
complex to stem-loop pre-miRNAs, which are then further processed by 
the second RNase, Dicer, to short, double-strand duplexes. 
•  Eventually, one of the functional strands in the resulting duplexes is 
preserved, forming a functional complex with the RISC proteins, and 
acts as guiding strands for specific recognition. Currently, several RNA-
binding proteins have been found to affect this canonical pathway with 
some that are involved in the regulation of cancer progression. 
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Examples 
• Lin-28 is the most studied RNA-binding protein being capable of 
regulating let-7 biogenesis. Overexpression of Lin-28 has been 
shown as an unfavorable prognostic marker in human cancers. Lin-
28 modulates the structural alternation of pre-let-7g to inhibit Dicer 
dependent processing. 
• The KH-type splicing regulatory protein (KSRP) was identified to 
enhance both Drosha- and Dicer-mediated miRNA processing 
through interaction with specific sequences in the loop region of a 
subset of pri-miRNAs. Knockdown of KSRP represses the 
expression of specific mature miRNAs, such as let-7a and miR-206, 
and consequently affects cell proliferation and differentiation. 
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5. miRNA-miRNA interaction 
• After processing, mature miRNAs are produced as functional 
strands, loaded onto miRISC, and targeted to specific 3’UTRs, 
thereafter. 
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Examples 
• In addition to the binding between miRNA and 3’UTR of its target 
mRNA, recently identified a direct interaction between two individual 
miRNAs, miR-107 and let-7. 
• It was identified the essential role of an internal loop within the miR-
107::let-7 duplex, which provides important clues for further 
investigation on the underlying mechanism. MiR-107 mitigates the 
tumor suppressive effects of let-7, and thus facilitating cancer 
progression. 
30 
31 
